Provided by Tiger Trade Technology Pte. Ltd.

MDxHealth, Inc.

2.05
+0.07503.81%
Volume:83.09K
Turnover:169.36K
Market Cap:105.04M
PE:-3.05
High:2.07
Open:1.97
Low:1.97
Close:1.97
52wk High:5.33
52wk Low:1.67
Shares:51.36M
Float Shares:35.02M
Volume Ratio:1.20
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6700
EPS(LYR):-0.6700
ROE:-2440.41%
ROA:-5.90%
PB:-8.69
PE(LYR):-3.05

Loading ...

MDxHealth Sets May 28, 2026 Shareholders’ Meetings to Approve 2025 Accounts and Governance Moves

TIPRANKS
·
Yesterday

MDxHealth CEO, director Michael McGarrity files initial beneficial ownership statement

Reuters
·
Apr 14

MDxHealth files Form 3 as EVP, general counsel Joseph Sollee reports ownership

Reuters
·
Apr 14

MDxHealth CFO Ron Kalfus files initial beneficial ownership statement

Reuters
·
Apr 14

MDxHealth files Form 3 as director Don M. Hardison reports initial ownership

Reuters
·
Apr 11

MDxHealth files Form 3 for director Sanford Jay Siegel

Reuters
·
Apr 10

MDxHealth files Form 3 as director Hilde Windels reports beneficial ownership

Reuters
·
Apr 10

MDxHealth files initial beneficial ownership statement for director Koen Hoffman

Reuters
·
Apr 10

MDxHealth FY25 net loss narrows 12% to $33.5 million; revenue rises 20% to $107.9 million

Reuters
·
Apr 03

Analysts Are Bullish on Top Healthcare Stocks: Protagonist Therapeutics (PTGX), MDxHealth (MDXH)

TIPRANKS
·
Mar 23

MDxHealth management to meet virtually with Willlam Blair

TIPRANKS
·
Mar 19

MDxHealth SA director MVM Partners reports 4.7 million ordinary shares in initial beneficial ownership filing

Reuters
·
Mar 19

MDxHealth reports Oxford ProMPT study shows GPS test predicts 6-year failure-free outcomes in 409 prostate cancer patients

Reuters
·
Mar 17

BTIG Keeps Their Buy Rating on MDxHealth (MDXH)

TIPRANKS
·
Mar 05

MDxHealth: Temporary Q4 Headwinds, Strong 2026 Growth Outlook and Undervalued Buy Opportunity

TIPRANKS
·
Feb 27

MDxHealth: Accelerating Growth, Margin Expansion, and Strengthening Clinical Evidence Support Buy Rating

TIPRANKS
·
Feb 27

MDxHealth reports Q4 EPS (17c) vs. (14c) last year

TIPRANKS
·
Feb 27

mdxhealth Q4 revenue rises 19% to USD 29.5 million

Reuters
·
Feb 27

MDxHealth Q4 EPS $(0.17) Misses $(0.13) Estimate, Sales $29.545M Miss $30.530M Estimate

Benzinga
·
Feb 27

MDxHealth Announces Fourth Quarter and Full-Year 2025 Financial Results

THOMSON REUTERS
·
Feb 27